Abstract
Drugs are bioactive agents used to treat or prevent diseases and illnesses through chemical action in the body. In order for a drug to be effective, it has to be at the site of cause of the illness, whether it is an infection, a blockage of an artery, pain, or some other malfunction of the bodily organs or tissues due to genetic causes or a trauma or aging. In order for the drug to reach this target site, it has to be introduced to the body (administration), cross barriers (distribution), get modified by the enzymes within the body (metabolism), and be removed from the body (elimination or excretion). All these processes affect the rate, dose at the target, efficacy, and the fate of the drug. In order for the drug to have prolonged or predetermined period of presence and sufficiently high concentration and to be localized specifically at the target tissue, “controlled release systems” are designed. All the abovementioned topics have to be discussed before a controlled release system can be designed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Pollack IP, Quigley HA, Harbin TS (1976) The Ocusert pilocarpine system: advantages and disadvantages. South Med J 69(10):1296–1298
Richa T, Gaurav S (2012) Promising implication of ocuserts in ocular disease. J Drug Deliv Ther 2(2):18–25
Wang Y, Kim H-J, Vunjak-Novakovic G, Kaplan DL (2006) Stem cell-based tissue engineering with silk biomaterials. Biomaterials 27:6064–6082
Sill TJ, von Recum HA (2008) Electrospinning: applications in drug delivery and tissue engineering. Biomaterials 29(13):1989–2006
Kenar H (2008) PhD Thesis, METU Department of Biotechnology
Li D, Xia Y (2004) Electrospinning of nanofibers: reinventing the wheel? Adv Mater 16(14):1151–1170
Goldberg M, Langer R, Jia X (2007) Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 18(3):241–268
Yilgor P (2009) PhD Thesis, METU Department of Biotechnology
Eke G (2011) Biopolymer Based Nano-Microparticles as Drug Carriers for the Treatment of Skin Diseases. MSc Thesis, Middle East Technical University, Ankara, Turkey.
Yucel D (2009) Stem Cell Based Nerve Tissue Engineering on Patterned Constructs. PhD. Thesis, Middle East Technical University, Ankara, Turkey.
Khan IU, Serra CA, Anton N, Vandamme T (2013) Microfluidics: a focus on improved cancer targeted drug delivery systems. J Control Release 172:1065–1074
Baek SE, Lee KH, Park YS, Oh D-K, Oh S, Kim K-S, Kim D-E (2014) RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo. J Control Release 196:234–242
Tavano L, de Cindio B, Picci N, Ioele G, Muzzalupo R (2014) Drug compartmentalization as strategy to improve the physico-chemical properties of diclofenac sodium loaded niosomes for topical applications. Biomed Microdevices 16(6):851–858
Fox ME, Szoka FC, Fréchet JMJ (2009) Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res 42(8):1141–1151
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this chapter
Cite this chapter
Hasirci, V., Hasirci, N. (2018). Controlled Release Systems. In: Fundamentals of Biomaterials. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-8856-3_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8856-3_17
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-8854-9
Online ISBN: 978-1-4939-8856-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)